Join Growin Stock Community!

鑽石投資6901.TW Overview

TW StockOthers
(No presentation for 6901)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

鑽石投資（6901）Overall Performance

鑽石投資（6901）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

鑽石投資（6901） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

鑽石投資（6901）Key Information

鑽石投資（6901）Profile

Diamond Biofund Inc. is a venture capital firm specializing in early to late stage investments. The firm typically invest in Greater China markets with focus in biotechnology, new drug development, innovative and high precision medical equipment, and medical services. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

鑽石投資（6901）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.26
PE Ratio (TTM)
-
Forward PE
9.40
PS Ratio (TTM)
288.67
PB Ratio
1.53
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-3475.69%
Net Margin
-3943.14%
Revenue Growth (YoY)
105.65%
Profit Growth (YoY)
-20.66%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
28.56%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.26
PE Ratio (TTM)
-
Forward PE
9.40
PS Ratio (TTM)
288.67
PB Ratio
1.53
Price-to-FCF
-
Gross Margin
-3475.69%
Net Margin
-3943.14%
Revenue Growth (YoY)
105.65%
Profit Growth (YoY)
-20.66%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
28.56%
default symbol

6901

鑽石投資

16.55D

-3.32%

(-0.03)

  • When is 6901's latest earnings report released?

    The most recent financial report for 鑽石投資 (6901) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6901's short-term business performance and financial health. For the latest updates on 6901's earnings releases, visit this page regularly.

  • How is 6901's revenue growth?

    In the latest financial report, 鑽石投資 (6901) announced revenue of 0, with a Year-Over-Year growth rate of -100%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 6901 have?

    At the end of the period, 鑽石投資 (6901) held Total Cash and Cash Equivalents of 2.8B, accounting for 0.3 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is 6901's EPS continuing to grow?

    According to the past four quarterly reports, 鑽石投資 (6901)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 6901?

    鑽石投資 (6901)'s Free Cash Flow (FCF) for the period is 216.96M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 1,563.35% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.